WizMediBio Signs Contract with the Wisconsin Alumni Research Foundation (WARF) for Botulinum Toxin Strain

×

错误信息

  • Notice: Undefined property: stdClass::$ds_changed 在 eval() (行 16/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url 在 eval() (行 20/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title 在 eval() (行 20/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ds_changed 在 eval() (行 16/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url 在 eval() (行 20/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title 在 eval() (行 20/var/www/7/modules/php/php.module(80) : eval()'d code).

The A1 botulinum toxin currently dominates the market and as a novel subtype, A6 presents itself as a challenger.